Dr. rer.nat Elke Hiendlmeyer
Clinical Trials Unit · Dept. Direktion
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2(nd) -line therapy for relapsed and refractory multiple myeloma - a phase II trial
Mey U, Ruefer A, Ziske C, Knauf W, Cathomas R, von Moos R, Hitz F, Sauter R, Hiendlmeyer E, Cantoni N, Bargetzi M, Fischer N, Doerfel S, Brugger W, Schwarb H, Pederiva S, Schwarzer A, Dechow T, Jehner P, Rauh J, Taverna C, Schmid M, Schmidt-Hieber M, Driessen C. Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2(nd) -line therapy for relapsed and refractory multiple myeloma - a phase II trial. Br J Haematol 2016
16.12.2016Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2(nd) -line therapy for relapsed and refractory multiple myeloma - a phase II trial
16.12.2016Br J Haematol 2016
Mey Ulrich J M, Ruefer Axel, Ziske Carsten, Knauf Wolfgang, Cathomas Richard, von Moos Roger, Hitz Felicitas, Sauter Rafael, Hiendlmeyer Elke, Cantoni Nathan, Bargetzi Mario, Fischer Natalie, Doerfel Steffen, Brugger Wolfram, Schwarb Heike, Pederiva Stefanie, Schwarzer Andreas, Dechow Tobias, Jehner Paul, Rauh Jacqueline, Taverna Christian J, Schmid Mathias, Schmidt-Hieber Martin, Driessen Christoph
p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors
Wassermann S, Kirchner T, Brabletz T, Merkel S, Reu S, Kriegl L, Haynl A, Hlubek F, Horst D, Palmqvist R, Hiendlmeyer E, Scheel S, Jung A. p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors. Gastroenterology 2009; 136:196-205.e2.
01.01.2009p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors
01.01.2009Gastroenterology 2009; 136:196-205.e2
Wassermann Stella, Kirchner Thomas, Brabletz Thomas, Merkel Susanne, Reu Simone, Kriegl Lydia, Haynl Angela, Hlubek Falk, Horst David, Palmqvist Richard, Hiendlmeyer Elke, Scheel Silvio K, Jung Andreas
beta-Catenin regulates the expression of tenascin-C in human colorectal tumors
Beiter K, Hiendlmeyer E, Brabletz T, Hlubek F, Haynl A, Knoll C, Kirchner T, Jung A. beta-Catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 2005; 24:8200-4.
08.12.2005beta-Catenin regulates the expression of tenascin-C in human colorectal tumors
08.12.2005Oncogene 2005; 24:8200-4
Beiter Katharina, Hiendlmeyer Elke, Brabletz Thomas, Hlubek Falk, Haynl Angela, Knoll Claudia, Kirchner Thomas, Jung Andreas
Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin
Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, Kirchner T. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs (Print) 2005; 179:56-65.
01.01.2005Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin
01.01.2005Cells Tissues Organs (Print) 2005; 179:56-65
Brabletz Thomas, Hlubek Falk, Spaderna Simone, Schmalhofer Otto, Hiendlmeyer Elke, Jung Andreas, Kirchner Thomas
Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors
Hiendlmeyer E, Kirchner T, Brabletz T, Reuning U, van Beest M, Knoll C, Koch C, Dimmler A, Haynl A, Hlubek F, Wassermann S, Regus S, Jung A. Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors. Cancer Res 2004; 64:1209-14.
15.02.2004Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors
15.02.2004Cancer Res 2004; 64:1209-14
Hiendlmeyer Elke, Kirchner Thomas, Brabletz Thomas, Reuning Ute, van Beest Moniek, Knoll Claudia, Koch Claudia, Dimmler Arno, Haynl Angela, Hlubek Falk, Wassermann Stella, Regus Susanne, Jung Andreas
T-cell factor-4 frameshift mutations occur frequently in human microsatellite instability-high colorectal carcinomas but do not contribute to carcinogenesis
Ruckert S, Kirchner T, Brabletz T, Rüschoff J, Koch C, Haynl A, Dietmaier W, Beyser K, Oswald U, Brueckl W, Hiendlmeyer E, Jung A. T-cell factor-4 frameshift mutations occur frequently in human microsatellite instability-high colorectal carcinomas but do not contribute to carcinogenesis. Cancer Res 2002; 62:3009-13.
01.06.2002T-cell factor-4 frameshift mutations occur frequently in human microsatellite instability-high colorectal carcinomas but do not contribute to carcinogenesis
01.06.2002Cancer Res 2002; 62:3009-13
Ruckert Stefan, Kirchner Thomas, Brabletz Thomas, Rüschoff Josef, Koch Claudia, Haynl Angela, Dietmaier Wolfgang, Beyser Kurt, Oswald Ursula, Brueckl Wolfgang M, Hiendlmeyer Elke, Jung Andreas
Oligoclonality of early lesions of the urothelium as determined by microdissection-supported genetic analysis
Stoehr R, Hartmann A, Hiendlmeyer E, Mürle K, Wieland W, Knuechel R. Oligoclonality of early lesions of the urothelium as determined by microdissection-supported genetic analysis. Pathobiology 2000; 68:165-72.
01.01.2000Oligoclonality of early lesions of the urothelium as determined by microdissection-supported genetic analysis
01.01.2000Pathobiology 2000; 68:165-72
Stoehr R, Hartmann A, Hiendlmeyer Elke, Mürle K, Wieland W, Knuechel R